June 12, 2007

This is an "oldie but goodie" post about zyprexa; Must reading if you see Big Pharma as on of the side effects of empire building . Be sure to read the whole article by pushing the link. Simply horrifying.

One more time, fascism is the blending of government and Big Business, as defined by Mussolini himself ...


Eli Lilly, Zyprexa & the Bush family
The diseasing of our malaise



http://zmagsite.zmag.org/May2004/levine0504.html


More
than one journalist has uncovered corrupt connections
between the Bush Family, psychiatry, and Eli Lilly &
Company, the giant pharmaceutical corporation. While
previous Lillygates have been more colorful, Lilly’s
soaking state Medicaid programs with Zyprexa—its
blockbuster, antipsychotic drug—may pack the greatest
financial wallop. Worldwide in 2003, Zyprexa grossed
$4.28 billion, accounting for slightly more than one-third
of Lilly’s total sales. In the United States in
2003, Zyprexa grossed $2.63 billion, 70 percent of that
attributable to government agencies, mostly Medicaid.

Historically, the exposure of any single Lilly machination—though

sometimes disrupting it—has not weakened the Bush-psychiatry-Lilly
relationship. In the last decade, some of the more widely
reported Eli Lilly intrigues include:



  • Influencing the Homeland Security Act
    to protect itself from lawsuits

  • Accessing confidential patient records for a Prozac
    sample mailing

  • Rigging the Wesbecker Prozac-violence trial
A sample of those who have been on the Eli Lilly payroll includes

  • Former President George Herbert Walker Bush (one-time
    member of the Eli Lilly board of directors)

  • Former CEO of Enron, Ken Lay (one-time member of the
    Eli Lilly board of directors)

  • George W. Bush’s former director of Management
    and Budget, Mitch Daniels (a former Eli Lilly vice
    president)

  • George W. Bush’s Homeland Security Advisory Council
    member, Sidney Taurel (current CEO of Eli Lilly)

  • The National Alliance for the Mentally Ill (a recipient
    of Eli Lilly funding)

In 2002, British and Japanese regulatory agencies warned
that Zyprexa may be linked to diabetes, but even after
the FDA issued a similar warning in 2003, Lilly’s
Zyprexa train was not derailed, as Zyprexa posted a
16 percent gain over 2002. The growth of Zyprexa has
become especially vital to Lilly because Prozac—Lilly’s
best-known product, which once annually grossed over
$2 billion—having lost its patent protection, continues
its rapid decline, down to $645.1 million in 2003.

Bruce
E. Levine, PhD, is a psychologist and author of
Commonsense
Rebellion: Taking Back Your Life from
Drugs,
Shrinks, Corporations and a World Gone Crazy

(New York-London: Continuum, 2003).

No comments:

ShareThis